Terveystalo Oyj
OMXH:TTALO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (7.9), the stock would be worth €10.61 (39% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 5.7 | €7.64 |
0%
|
| 3-Year Average | 7.9 | €10.61 |
+39%
|
| 5-Year Average | 8.1 | €10.8 |
+41%
|
| Industry Average | 6.9 | €9.21 |
+20%
|
| Country Average | 11.5 | €15.42 |
+102%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
€1.6B
|
/ |
Jan 2026
€241.4m
|
= |
|
|
€1.6B
|
/ |
Dec 2026
€252.1m
|
= |
|
|
€1.6B
|
/ |
Dec 2027
€265.2m
|
= |
|
|
€1.6B
|
/ |
Dec 2028
€275m
|
= |
|
|
€1.6B
|
/ |
Dec 2029
€282.6m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| FI |
T
|
Terveystalo Oyj
OMXH:TTALO
|
967.6m EUR | 5.7 | 10.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 14.2 | 56 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.7B EUR | 7.8 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD | 0 | 12.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 9 | 23.3 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 9.2 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 11.7 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 11.9 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 5.3 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | -30.5 | -27.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 7.2 | 13.9 |
Market Distribution
| Min | 0.5 |
| 30th Percentile | 8.7 |
| Median | 11.5 |
| 70th Percentile | 16.5 |
| Max | 368.3 |
Other Multiples
Terveystalo Oyj
Glance View
Terveystalo Oyj, a leading figure in Finland's private healthcare sector, paints a comprehensive picture of modern healthcare services, effectively bridging the gap between medical expertise and patient-centered care. Established in 2001, the company operates a robust network of clinics and hospitals across Finland, addressing a broad spectrum of health needs from occupational health services to specialized medical treatments and diagnostics. By integrating cutting-edge technology and innovative healthcare solutions, Terveystalo ensures efficient service delivery and high-quality patient care. The company's strength lies in its expansive reach and diverse service offerings, which cater to both corporate clients and individual patients, thus cementing its role as a pillar of health and wellness in the Finnish market. Financially, Terveystalo generates revenue through a multi-faceted business model. The company offers occupational health services, which are a significant part of its income stream, as many Finnish companies utilize these services for their employees, ensuring workplace wellness and compliance with health regulations. Additionally, revenue flows from private consultations, medical procedures, and an array of diagnostic services. Terveystalo's investment in digital health tools, such as online consultations and telemedicine, further monetizes their operations by offering convenient access to healthcare, thereby broadening their customer base. This business strategy not only aligns with global trends towards digitalization but also positions Terveystalo as a resilient player in the face of evolving healthcare demands.
